eli lilly gip/glp-1 FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Novo Nordisk vs Eli Lilly:
Description
Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes
These medications can also be expensive and hard to find
In this regard, DPP-4 resistant GLP-1 analogues including exenatide, liraglutide, albiglutide, dulaglutide are FDA approved and these analogues exhibit increased half-life
It requires insight into what is changing in real-time, not what happened last quarter
Today, VOO is the world's largest ETF with $1.4 trillion in net assets
You have related health conditions like type 2 diabetes or cardiovascular disease
